DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY (DAANCE)
DANCE-BASED AVENUES TO ADVANCE NONPHARMACOLOGIC TREATMENT OF CHEMOTHERAPY EFFECTS (DAANCE): A MULTICENTER TRIAL
Sponsor: Emory University
Listed as NCT06749210, this PHASE2 trial focuses on Cancer of the Breast and Chemotherapy-induced Neuropathy and remains actively recruiting participants. Sponsored by Emory University, it has been updated 6 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Dec 2025 — Present [monthly]
Recruiting PHASE2
-
Aug 2025 — Dec 2025 [monthly]
Recruiting PHASE2
-
Jun 2025 — Aug 2025 [monthly]
Recruiting PHASE2
-
Apr 2025 — Jun 2025 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Not Yet Recruiting PHASE2
▶ Show 1 earlier version
-
Jan 2025 — Feb 2025 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
- National Institute on Aging (NIA)
- Ohio State University Comprehensive Cancer Center
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .